Catalyst Wire Dossier Catalyst Wire Dossier

Ciprofloxacin (generic)

ciprofloxacin · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ciprofloxacin (generic), covering 2022-12-19 to 2022-12-19. Get the full timeline:

Most recent: FDA Approved: CIPROFLOXACIN — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

See pricing